VERINNOGEN LIMITED

Active Cambridge

Manufacture of electronic measuring, testing etc. equipment, not for industrial process control

5 employees website.com
Life sciences and medical technology Manufacture of electronic measuring, testing etc. equipment, not for industrial process controlManufacture of optical precision instruments +1
V

VERINNOGEN LIMITED

Manufacture of electronic measuring, testing etc. equipment, not for industrial process control

Founded 15 Mar 2021 Active Cambridge, England 5 employees website.com
Life sciences and medical technology Manufacture of electronic measuring, testing etc. equipment, not for industrial process controlManufacture of optical precision instrumentsManufacture of medical and dental instruments and supplies
Accounts Submitted 18 Dec 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 27 Mar 2026 Next due 28 Mar 2027 11 months remaining
Net assets £539K £438K 2024 year on year
Total assets £573K £438K 2024 year on year
Total Liabilities £35K £897 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Unit 9 Quy Court Cambridge CB25 9AU England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for VERINNOGEN LIMITED (13266666), an active life sciences and medical technology company based in Cambridge, England. Incorporated 15 Mar 2021. Manufacture of electronic measuring, testing etc. equipment, not for industrial process control. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£489.50k

Increased by £411.29k (+526%)

Net Assets

£538.67k

Increased by £438.43k (+437%)

Total Liabilities

£34.75k

Decreased by £897.00 (-3%)

Turnover

N/A

Employees

5

Increased by 1 (+25%)

Debt Ratio

6%

Decreased by 20 (-77%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 103,896 Shares £10.39 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Nov 2022103,896£10.39£0

Officers

Officers

2 active 1 resigned
Status
Johnson, Timothy IsaacDirectorBritishUnited Kingdom3615 Mar 2021Active
Jones, Christopher MichaelDirectorAmericanEngland5915 Jan 2024Active

Shareholders

Shareholders (3)

Michael Peter Irvine
45.3%
Timothy Isaac Johnson
45.3%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Mr Michael Peter Irvine

Ceased 16 Jan 2026

Ceased

Mr Timothy Isaac Johnson

Ceased 16 Jan 2026

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Mar 2026Confirmation StatementConfirmation statement made on 2026-03-14 with updates
27 Mar 2026Persons With Significant ControlNotification of a person with significant control statement
18 Mar 2026Persons With Significant ControlCessation of Michael Peter Irvine as a person with significant control on 2026-01-16
18 Mar 2026Persons With Significant ControlCessation of Timothy Isaac Johnson as a person with significant control on 2026-01-16
2 Feb 2026IncorporationMemorandum Articles
27 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-03-14 with updates

27 Mar 2026 Persons With Significant Control

Notification of a person with significant control statement

18 Mar 2026 Persons With Significant Control

Cessation of Michael Peter Irvine as a person with significant control on 2026-01-16

18 Mar 2026 Persons With Significant Control

Cessation of Timothy Isaac Johnson as a person with significant control on 2026-01-16

2 Feb 2026 Incorporation

Memorandum Articles

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-14 with updates

3 weeks ago on 27 Mar 2026

Notification of a person with significant control statement

3 weeks ago on 27 Mar 2026

Cessation of Michael Peter Irvine as a person with significant control on 2026-01-16

1 months ago on 18 Mar 2026

Cessation of Timothy Isaac Johnson as a person with significant control on 2026-01-16

1 months ago on 18 Mar 2026

Memorandum Articles

2 months ago on 2 Feb 2026